# An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

> **NCT00092898** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 30 (actual)

## Conditions studied

- Lipid Metabolism, Inborn Errors
- Heart Disease

## Interventions

- **DRUG:** MK0653, ezetimibe
- **DRUG:** Comparator: placebo

## Key facts

- **NCT ID:** NCT00092898
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2005-09
- **Final completion:** 2005-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092898, "An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00092898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*